Skip to main content
EMR
NYSE Manufacturing

Emerson Reports Strong Q1 Underlying Orders, Exceeds Profitability Expectations, Updates 2026 Outlook

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
7
Price
$150.353
Mkt Cap
$85.45B
52W Low
$90.055
52W High
$154.04
Market data snapshot near publication time

summarizeSummary

Emerson reported Q1 2026 results with strong underlying orders and better-than-expected profitability, while updating its full-year 2026 financial outlook and announcing a $1.0 billion share repurchase plan.


check_boxKey Events

  • Q1 2026 Financial Performance

    Reported Q1 2026 GAAP EPS of $1.07 (up 5%) and Adjusted EPS of $1.46 (up 6%), with underlying orders growing 9% and net sales increasing 4%.

  • Profitability Exceeded Expectations

    Management stated the company "met sales commitments and exceeded expectations for profitability," driven by robust demand in automation technology.

  • Cash Flow Decline

    Operating cash flow decreased 10% to $699 million, and free cash flow decreased 13% to $602 million compared to the prior year.

  • Updated Full-Year 2026 Outlook

    Provided revised guidance for fiscal 2026, including approximately 4% underlying sales growth and adjusted EPS between $6.40 and $6.55.


auto_awesomeAnalysis

Emerson Electric Co. reported its first-quarter fiscal 2026 results, showcasing strong underlying orders growth and exceeding profitability expectations. Despite a decline in operating and free cash flow, the company delivered increased GAAP and Adjusted EPS. The updated full-year 2026 outlook provides revised expectations for sales, earnings, and cash flow, alongside a commitment to return capital through dividends and a $1.0 billion share repurchase program. Investors should monitor the company's ability to convert strong orders into improved cash flow in subsequent quarters.

At the time of this filing, EMR was trading at $150.35 on NYSE in the Manufacturing sector, with a market capitalization of approximately $85.4B. The 52-week trading range was $90.06 to $154.04. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed EMR - Latest Insights

EMR
Apr 21, 2026, 1:04 AM EDT
Source: Zawya
Importance Score:
7
EMR
Feb 03, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7